Switch to: References

Add citations

You must login to add citations.
  1. The ethical anatomy of payment for research participants.Joanna Różyńska - 2022 - Medicine, Health Care and Philosophy 25 (3):449-464.
    In contrast to most publications on the ethics of paying research subjects, which start by identifying and analyzing major ethical concerns raised by the practice (in particular, risks of undue inducement and exploitation) and end with a set of—more or less well-justified—ethical recommendations for using payment schemes immune to these problems, this paper offers a systematic, principle-based ethical analysis of the practice. It argues that researchers have aprima faciemoral obligation to offer payment to research subjects, which stems from the principle (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Promoting Ethical Payment in Human Infection Challenge Studies.Holly Fernandez Lynch, Thomas C. Darton, Jae Levy, Frank McCormick, Ubaka Ogbogu, Ruth O. Payne, Alvin E. Roth, Akilah Jefferson Shah, Thomas Smiley & Emily A. Largent - 2021 - American Journal of Bioethics 21 (3):11-31.
    To prepare for potential human infection challenge studies involving SARS-CoV-2, we convened a multidisciplinary working group to address ethical questions regarding whether and how much SAR...
    Download  
     
    Export citation  
     
    Bookmark   17 citations  
  • A Proposal for Fair Compensation for Research Participants.Emily E. Anderson - 2019 - American Journal of Bioethics 19 (9):62-64.
    Volume 19, Issue 9, September 2019, Page 62-64.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Coercive Offers Without Coercion as Subjection.William R. Smith & Benjamin Rossi - 2019 - American Journal of Bioethics 19 (9):64-66.
    Volume 19, Issue 9, September 2019, Page 64-66.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Appraising Harm in Phase I Trials: Healthy Volunteers' Accounts of Adverse Events.Lisa McManus, Arlene Davis, Rebecca L. Forcier & Jill A. Fisher - 2019 - Journal of Law, Medicine and Ethics 47 (2):323-333.
    While risk of harm is an important focus for whether clinical research on humans can and should proceed, there is uncertainty about what constitutes harm to a trial participant. In Phase I trials on healthy volunteers, the purpose of the research is to document and measure safety concerns associated with investigational drugs, and participants are financially compensated for their enrollment in these studies. In this article, we investigate how characterizations of harm are narrated by healthy volunteers in the context of (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations